Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression

被引:41
|
作者
Cheng, Xingguo [1 ]
Maher, Jonathan [1 ]
Lu, Hong [1 ]
Klaassen, Curtis D. [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
关键词
D O I
10.1124/mol.106.025122
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several examples of gender-divergent pharmacokinetics exist in humans and experimental animals, and one reason for these variations may be gender differences in transporter expression. Organic anion transporting polypeptides (Oatp) are transporters involved in hepatic and renal uptake of many organic compounds. In mouse livers, Oatp1a1 is male-predominant, whereas Oatp1a4 is female-predominant. However, in kidneys, Oatp1a1 and Oatp3a1 are both female-predominant. The purpose of the present study was to determine whether sex hormones and/ or growth hormone (GH) secretion patterns are responsible for the gender-specific Oatp expression in mice. Gonadectomized mice, GH-releasing hormone receptor-deficient little (lit/ lit) mice, and hypophysectomized mice were used with replacement of sex hormones or GH in male or female secretion patterns. Androgens increased Oatp1a1 mRNA in liver and kidney, whereas male-pattern GH administration increased Oatp1a1 mRNA in livers but not in kidneys. Hepatic Oatp1a4 mRNA levels were decreased by both androgens and male-pattern GH administration. In kidneys, Oatp3a1 mRNA expression was only induced by androgen treatment. In conclusion, gender-divergent Oatp expression in liver is caused by male-pattern GH secretion pattern and androgens. In kidney, gender-divergent Oatp expression is exclusively caused by stimulation by androgens.
引用
收藏
页码:1291 / 1297
页数:7
相关论文
共 50 条
  • [1] Endocrine regulation of gender-divergent mouse organic anion-transporting polypeptide (Oatp) expression (vol 70, pg 1291, 2006)
    Cheng, X.
    Maher, J.
    Lu, H.
    Klaassen, C. D.
    MOLECULAR PHARMACOLOGY, 2008, 73 (04) : 1331 - 1331
  • [2] Organic anion-transporting polypeptide (OATP) transporter family and drug disposition
    Kim, RB
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 : 1 - 5
  • [3] Regulation of the rat organic anion-transporting polypeptide 4 (Oatp4) by bile acids
    Rost, D
    Herrmann, T
    Mayer, D
    Sauer, P
    Stieger, B
    Meier, PJ
    Stremmel, W
    Stiehl, A
    BILE ACIDS: FROM GENOMICS TO DISEASE AND THERAPY, 2003, 129 : 89 - 91
  • [4] Regulation of the organic anion-transporting polypeptide of human liver
    Kullak-Ublick, GA
    Beuers, U
    Meier, PJ
    Wolkoff, AW
    Paumgartner, G
    BILE ACIDS IN HEPATOBILIARY DISEASES: BASIC RESEARCH AND CLINICAL APPLICATION, 1997, 93 : 104 - 106
  • [5] Characterization of an organic anion-transporting polypeptide (OATP-B) in human placenta
    St-Pierre, MV
    Hagenbuch, B
    Ugele, B
    Meier, PJ
    Stallmach, T
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04): : 1856 - 1863
  • [6] Pharmacogenomics of organic anion-transporting polypeptides (OATP)
    Tirona, RG
    Kim, RB
    ADVANCED DRUG DELIVERY REVIEWS, 2002, 54 (10) : 1343 - 1352
  • [7] Localization and function of the organic anion-transporting polypeptide Oatp2 in rat liver
    Reichel, C
    Gao, B
    Van Montfoort, J
    Cattori, V
    Rahner, C
    Hagenbuch, B
    Stieger, B
    Kamisako, T
    Meier, PJ
    GASTROENTEROLOGY, 1999, 117 (03) : 688 - 695
  • [8] Distribution of organic anion-transporting polypeptide 2 (oatp2) and oatp3 in the rat retina
    Ito, A
    Yamaguchi, K
    Onogawa, T
    Unno, M
    Suzuki, T
    Nishio, T
    Suzuki, T
    Sasano, H
    Abe, T
    Tamai, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (03) : 858 - 863
  • [9] Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B
    Fuchikami, H
    Satoh, H
    Tsujimoto, M
    Ohdo, S
    Ohtani, H
    Sawada, Y
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) : 577 - 582
  • [10] Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B
    Satoh, H
    Yamashita, F
    Tsujimoto, M
    Murakami, H
    Koyabu, N
    Ohtani, H
    Sawada, Y
    DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) : 518 - 523